{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:45:36Z","timestamp":1792896336703,"version":"4.5.0"},"reference-count":26,"publisher":"Massachusetts Medical Society","issue":"5","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"name":"CinCor Pharma, Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2023,2,2]]},"DOI":"10.1056\/nejmoa2213169","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T16:20:13Z","timestamp":1667838013000},"page":"395-405","source":"Crossref","is-referenced-by-count":394,"title":["Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension"],"prefix":"10.1056","volume":"388","author":[{"given":"Mason W.","family":"Freeman","sequence":"first","affiliation":[{"name":"From CinCor Pharma (M.W.F., Y.-D.H., W.M., C.P.) and Brigham and Women\u2019s Hospital, Harvard Medical School (D.L.B.) \u2014 both in Boston; CinRx Pharma (M.P., J.I., B.M.) and Medpace (N.A., A.S.) \u2014 both in Cincinnati; and the Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London (M.J.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Di","family":"Halvorsen","sequence":"additional","affiliation":[{"name":"From CinCor Pharma (M.W.F., Y.-D.H., W.M., C.P.) and Brigham and Women\u2019s Hospital, Harvard Medical School (D.L.B.) \u2014 both in Boston; CinRx Pharma (M.P., J.I., B.M.) and Medpace (N.A., A.S.) \u2014 both in Cincinnati; and the Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London (M.J.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Marshall","sequence":"additional","affiliation":[{"name":"From CinCor Pharma (M.W.F., Y.-D.H., W.M., C.P.) and Brigham and Women\u2019s Hospital, Harvard Medical School (D.L.B.) \u2014 both in Boston; CinRx Pharma (M.P., J.I., B.M.) and Medpace (N.A., A.S.) \u2014 both in Cincinnati; and the Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London (M.J.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie","family":"Pater","sequence":"additional","affiliation":[{"name":"From CinCor Pharma (M.W.F., Y.-D.H., W.M., C.P.) and Brigham and Women\u2019s Hospital, Harvard Medical School (D.L.B.) \u2014 both in Boston; CinRx Pharma (M.P., J.I., B.M.) and Medpace (N.A., A.S.) \u2014 both in Cincinnati; and the Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London (M.J.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Isaacsohn","sequence":"additional","affiliation":[{"name":"From CinCor Pharma (M.W.F., Y.-D.H., W.M., C.P.) and Brigham and Women\u2019s Hospital, Harvard Medical School (D.L.B.) \u2014 both in Boston; CinRx Pharma (M.P., J.I., B.M.) and Medpace (N.A., A.S.) \u2014 both in Cincinnati; and the Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London (M.J.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Pearce","sequence":"additional","affiliation":[{"name":"From CinCor Pharma (M.W.F., Y.-D.H., W.M., C.P.) and Brigham and Women\u2019s Hospital, Harvard Medical School (D.L.B.) \u2014 both in Boston; CinRx Pharma (M.P., J.I., B.M.) and Medpace (N.A., A.S.) \u2014 both in Cincinnati; and the Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London (M.J.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Murphy","sequence":"additional","affiliation":[{"name":"From CinCor Pharma (M.W.F., Y.-D.H., W.M., C.P.) and Brigham and Women\u2019s Hospital, Harvard Medical School (D.L.B.) \u2014 both in Boston; CinRx Pharma (M.P., J.I., B.M.) and Medpace (N.A., A.S.) \u2014 both in Cincinnati; and the Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London (M.J.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Alp","sequence":"additional","affiliation":[{"name":"From CinCor Pharma (M.W.F., Y.-D.H., W.M., C.P.) and Brigham and Women\u2019s Hospital, Harvard Medical School (D.L.B.) \u2014 both in Boston; CinRx Pharma (M.P., J.I., B.M.) and Medpace (N.A., A.S.) \u2014 both in Cincinnati; and the Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London (M.J.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Srivastava","sequence":"additional","affiliation":[{"name":"From CinCor Pharma (M.W.F., Y.-D.H., W.M., C.P.) and Brigham and Women\u2019s Hospital, Harvard Medical School (D.L.B.) \u2014 both in Boston; CinRx Pharma (M.P., J.I., B.M.) and Medpace (N.A., A.S.) \u2014 both in Cincinnati; and the Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London (M.J.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-6245","authenticated-orcid":false,"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[{"name":"From CinCor Pharma (M.W.F., Y.-D.H., W.M., C.P.) and Brigham and Women\u2019s Hospital, Harvard Medical School (D.L.B.) \u2014 both in Boston; CinRx Pharma (M.P., J.I., B.M.) and Medpace (N.A., A.S.) \u2014 both in Cincinnati; and the Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London (M.J.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8409-1082","authenticated-orcid":false,"given":"Morris J.","family":"Brown","sequence":"additional","affiliation":[{"name":"From CinCor Pharma (M.W.F., Y.-D.H., W.M., C.P.) and Brigham and Women\u2019s Hospital, Harvard Medical School (D.L.B.) \u2014 both in Boston; CinRx Pharma (M.P., J.I., B.M.) and Medpace (N.A., A.S.) \u2014 both in Cincinnati; and the Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London (M.J.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.018912"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000084"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051455"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu080"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.12191"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.11.006"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1803180"},{"key":"e_1_3_5_9_2","unstructured":"Centers for Disease Control and Prevention. Estimated hypertension prevalence treatment and control among U.S. adults. Atlanta: Department of Health and Human Services 2021 (https:\/\/millionhearts.hhs.gov\/data-reports\/hypertension-prevalence.html)."},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.787630"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.07716"},{"key":"e_1_3_5_12_2","doi-asserted-by":"crossref","unstructured":"Freeman MW Bond M Murphy B Hui J Isaacsohn J. Results from a phase 1 randomized double-blind multiple ascending dose study characterizing the pharmacokinetics and demonstrating the safety and selectivity of the aldosterone synthase inhibitor baxdrostat in healthy volunteers. Hypertens Res 2022 (https:\/\/www.nature.com\/articles\/s41440-022-01070-4).","DOI":"10.1038\/s41440-022-01070-4"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-00439-7"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.07.051"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.05.041"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.09.594"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2022.01.029"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2014-305540"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu364"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30071-8"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00257-3"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.09.038"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040135"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-69-4-896"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs388"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30240-0"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105835"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2213169","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T19:00:07Z","timestamp":1749668407000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2213169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,2,2]]}},"alternative-id":["10.1056\/NEJMoa2213169"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2213169","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742400277.793597766","asserted-by":"object"}]},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]}}}